Why Atossa Therapeutics (ATOS) Is Surging 38% Pre-Market?
Before the ring of the bell today, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, has been seeing a 30.24% jump in its stock price. At the close of the previous session, the stock was up 16.43% to close at $2.48. Over the past 5 sessions, the stock is down -8.49% while the decline […]